期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

间充质干细胞对固有免疫细胞调节作用的研究进展 被引量：3

原文传递
导出
摘要 近年来研究发现,间充质干细胞除具有支持体外造血、促进体内造血功能重建外,还具有较低的免疫原性,能够通过调节多种固有或适应性免疫细胞的功能,来调节机体的免疫反应。本文阐述了间充质干细胞对巨噬细胞、中性粒细胞、自然杀伤细胞以及树突状细胞的免疫调节作用。
作者 郭志祥 范慧敏 刘中民
机构地区 同济大学附属东方医院中德心脏研究所
出处 《现代免疫学》 CAS CSCD 北大核心 2011年第5期415-417,422,共4页 Current Immunology
基金 国家自然科学基金资助项目(81070073) 上海市科委资助项目(09411962200) 浦东新区卫生系统重点学科群建设资助项目(PKzxkq2010-01)
关键词 间充质干细胞 免疫细胞 免疫调节
分类号 R392 [医药卫生—免疫学]
  • 相关文献

参考文献24

  • 1Nemeth K, Leelahavanichkul A, Yuen PS, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2 dependent reprogramming of host macrophages to increase their interleukin-10 production[J]. Nat Med, 2009,15:42- 49.
  • 2熊思东.疾病发病中的巨噬细胞极化:机制与作用[J].现代免疫学,2010,30(5):353-360. 被引量：19
  • 3Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages [J]. Exp Hematol, 2009,37:1445-1453.
  • 4Zhang QZ, Su WR, Shi SH, et al. Human gingiva derived mesenchymal stem cells elicit polarization of M2 macrophages and enhance cutaneous wound healing[J]. Stem Cells, 2010, 28 : 1856-1868.
  • 5Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation[J]. Nat Rev, 2008,8 :958 -969.
  • 6Maggini J, Mirkin G, Bognanni I, et al. Mouse bone marrow derived mesenchymal stromal cells turn activated macro phages into a regulatory-like profile[J]. PLoS One, 2010,5:e9252.
  • 7Raffaghello L, Bianchi G, Bertolotto M, etal. Human mesenchymal stem ceils inhibit neutrophil apoptosis:a model for neutrophil preservation in the bone marrow niche[J]. Stem Cells, 2008,26 :151-162.
  • 8Maccario R, Podest M, Moretta A, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigen specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotype [J]. Haematologica, 2005,90:516-525.
  • 9Spaggiari GM, Capobianco A, Becchetti S, et al. Mesenchy- real stem cell natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL 2 induced NK cell proliferation[J]. Blood, 2006,107:1484 -1490.
  • 10Gotherstrom C, Lundqvist A, Duprez IR, et al. Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways[J]. Cytotherapy, 2011,13 : 269-278.

二级参考文献32

  • 1Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation[J].Nat Rev Immunol, 2008,8 : 958-969.
  • 2Stein M, Keshav S, Harris N, et al. Interleukin 4 potently enhances murine maerophage mannose receptor activity: a marker of alternative immunologic macrophage activation[J].J Exp Med,1992, 176:287-292.
  • 3Gordon S. Alternative activation of macrophages[J]. Nat Rev Immunol, 2003,3:23-35.
  • 4Martinez FO, Helming L, Gordon S. Alternative activation of macrophages:an immunologic functional perspective[J].Annu Rev Immunol, 2009,27:451-483.
  • 5Timmer AM, Nizet V. IKKI3/NF-κB and the miscreant macrophage[J]. J Exp Med,2008, 205:1655-1659.
  • 6Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions[J]. Immunity, 2010,32:593- 604.
  • 7Liu Y, Stewart KN, Bishop E, et al. Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo[J]. J Immunol, 2008, 180:6270-6278.
  • 8Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance [J].Nature, 2007,447 :1116- 1120.
  • 9Cramer T, Yamanishi Y, Clausen BE, et al. HIF-1alpha is essential for myeloid cell mediated inflammation [J]. Cell, 2003,113:419.
  • 10Ishii M, Wen H, Corsa CA, et al. Epigenetic regulation of the alternatively activated macrophage phenotype[J]. Blood, 2009 , 114:3244-3254.

共引文献18

同被引文献21

  • 1盛慧明,崔磊,李宁丽.间充质干细胞免疫负调节机制研究进展[J].现代免疫学,2007,27(2):161-164. 被引量：5
  • 2李焕萍,刘春蓉,张永亮.骨髓间充质干细胞在医学领域中的研究与应用[J].中国组织工程研究与临床康复,2007,11(28):5622-5625. 被引量：26
  • 3Beyer NN,da Silva ML.Mesenchymal stem cells:Isolation,in vitro expansion and characterization[J].Handb Exp Phar-macol,2006,174:249-282.
  • 4Scthe S,Scutt A,Stolzing A.Aging of mesenchymal stem cells[J].Ageing Res Rev,2006,5:91-116.
  • 5Dave L,Roelen BJvdM,Pietemella S.Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells[J].Hum Immunol,2009,70:16-23.
  • 6Li W,Ren G,Huang Y,et al.Mesenchymal stem cells:a double-edged sword in regulating immune responses [J].Cell Death Differ,2012,19:1505-1513.
  • 7Uccclli A,Moretta L,Pistoia V.Mesenchymal stem cells in heath and diease [J].Nat Rev Immunol,2008,8:726-736.
  • 8Le Blanc K,Tammik C,Zetterberg E,et at.HLA-expres-sion and immunologic propenies of differentiated and undifferentiated mesenchymal stem cells [J].Exp Hematol,2003,31:890-896.
  • 9Rasmusson I,Ringden O,Sundberg B,et al.Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes,but not activated cytotoxic T lymphocytes or natural killer cells[J].Transplantation,2003,76:1208-1213.
  • 10Niemeyer P,Seckinger A,Simank HG,et al.Allogenic transplantation of human vmesenchymal stem cells for tissue engineering purposes:an in vitro study[J].Orthopade,2004,33:1346-1353.

引证文献3

现代免疫学
2011年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部